~~<i id='AA193693EB'><strike id='AA193693EB'><tt id='AA193693EB'><pre id='AA193693EB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

knowledge

author：hotspot 2025-09-06 03:40:03 - browse：63792

People taking notes while sitting around a meeting table — Adobe

It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Sana to lay off nearly a third of staff, de

Wikipedia

hotspot

leisure time

explore

hotspot

CDCDirectorMandyCohenCliffOwen/APThenewdirectoroftheCentersforDiseaseControlandPrevention,MandyCohen

WSS

What it's like to live with paralysis for one psychologist

A Q&A with the global head of Boehringer Ingelheim's innovation unit

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

FDA panel signals lack of confidence in Amgen cancer drug data

A Q&A with the global head of Boehringer Ingelheim's innovation unit

VC firm General Catalyst wants to buy a health system

hotspot

knowledge

Wikipedia

Supreme Court strikes down use of affirmative action

Roche’s Alnylam deal shows drug firms interested in heart drugs

Virginia high school admissions case could be legal follow

Why age limits for politicians are a terrible idea

Medicare details structure of new drug price negotiation program

What to watch for from Zogenix and Amicus clinical trials

The high cost of giving birth even with insurance

Why age limits for politicians are a terrible idea

How to save PrEP access — and even expand it

What it's like to live with paralysis for one psychologist

hotspot

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

In the gardens at Boston Children's Hospital, families find sanctuary

VC firm General Catalyst wants to buy a health system

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

CDC Director Mandy Cohen on transparency, trust, and health

leisure time

explore

hotspot

hotspot